Population Pharmacokinetics and Safety of Solithromycin following Intravenous and Oral Administration in Infants, Children, and Adolescents
Daniel González(University of North Carolina at Chapel Hill), Michael Cohen‐Wolkowiez(Duke University), John S. Bradley(Rady Children's Hospital-San Diego), Theresa Jasion(Duke University), Felix Boakye‐Agyeman(Mayo Clinic), Claudia Espinosa(University of Louisville), Susan R. Mendley(University of Maryland, Baltimore), Amira Al‐Uzri(Oregon Health & Science University), Robert Hernandez(Melinta Therapeutics (United States)), Daniel K. Benjamin(Duke University), Kari Simonsen(Nebraska Medical Center), Laura P. James(University of Arkansas for Medical Sciences), Christoph P. Hornik(Duke University), Eva Tsonkova(National Institute of Emergency Medicine "Pirogov"), Lucila Marquez(Baylor College of Medicine), S Stoilov(National Institute of Emergency Medicine "Pirogov"), Felice C. Adler‐Shohet(Children's Hospital of Orange County), Miroslava Bosheva(Medical University Plovdiv), Kathryn Moffett(West Virginia University Hospitals)
Cited by 5
Related Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.2k
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
|Obesity|2021|199
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
|Clinical Therapeutics|2016|170